OMX Nordic 40 2729754 / SE0001809476
2’111.40
Pkt
-8.25
Pkt
-0.39
%
17:35:09
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 10.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 10.04.25 | ABB Sell | Deutsche Bank AG | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 08.04.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 08.04.25 | Nokia Buy | Deutsche Bank AG | |
| 08.04.25 | Nokia Market-Perform | Bernstein Research | |
| 08.04.25 | Ericsson Underperform | Bernstein Research | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 04.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Volvo AB Underperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | Volvo AB Underperform | Bernstein Research | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 27.03.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.03.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 27.03.25 | Volvo AB Buy | Jefferies & Company Inc. |